“…Early animal models of PB established that this drug can adversely affect nerve function ( Drake-Baumann & Seil, 1999 ; Hudson, Foster, & Kahng, 1985 ) and can also have gastrointestinal ( Kluwe, Page, Toft, Ridder, & Chung, 1990 ), muscular ( Adler, Deshpande, Foster, Maxwell, & Albuquerque, 1992 ), immune ( Peden-Adams et al, 2004 ) and cardiovascular ( Bernatova, Babal, Grubbs, & Morris, 2006 ) effects. Rodents given PB over time showed a number of locomotor, learning and behavioral deficits ( Abou-Donia, Dechkovskaia, Goldstein, Bullman, & Khan, 2002 ; Abou-Donia et al, 2001 ; van Haaren et al, 2001 ), despite showing no overt signs of cholinergic toxicity or illness. Three studies in rodent models found that the adverse effects of PB were enhanced by stressors ( Abdel-Rahman, Abou-Donia, El-Masry, Shetty, & Abou-Donia, 2004 ; Abdel-Rahman, Shetty, & Abou-Donia, 2002 ; Friedman et al, 1996 ).…”